Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|December 6, 2000
Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitorsC Ferlini, M Distefano, F Pignatelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 1999
A common pharmacophore for cytotoxic natural products that stabilize microtubulesI Ojima, S Chakravarty, T Inoue, et al.
Biochemistry|August 12, 1998
Identification of the domains of photoincorporation of the 3'- and 7-benzophenone analogues of taxol in the carboxyl-terminal half of murine mdr1b P-glycoproteinQ Wu, P Y Bounaud, S D Kuduk, et al.
Lab on a Chip|February 25, 2016
Hydrogel microstructure live-cell array for multiplexed analyses of cancer stem cells, tumor heterogeneity and differential drug response at single-element resolutionE Afrimzon, G Botchkina, N Zurgil, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2000
Synthesis and structure-activity relationships of new second-generation taxoidsI Ojima, T Wang, M L Miller, et al.
Mutagenesis|August 4, 2019
KRAS pathway expression changes in pancreatic cancer models by conventional and experimental taxanesM Oliverius, D Flasarova, B Mohelnikova-Duchonova, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 15, 2006
Metabolism of new-generation taxanes in human, pig, minipig and rat liver microsomesI Gut, I Ojima, R Vaclavikova, et al.
Biochemical and Biophysical Research Communications|October 3, 1996
Structural requirements of taxoids for nitric oxide and tumor necrosis factor production by murine macrophagesT Kirikae, I Ojima, F Kirikae, et al.
Journal of the National Cancer Institute|August 16, 2001
Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistanceM R Vredenburg, I Ojima, J Veith, et al.
International Journal of Cancer|September 25, 1997
Anti-proliferative activity of a new class of taxanes (14beta-hydroxy-10-deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cellsM Distefano, G Scambia, C Ferlini, et al.
Pageof 5